This paper is only available as a PDF. To read, Please Download here.
Abstract
Changes of plasma levels of apoproteins A-I, A-II and C-III were determined after
oral and intravenous fat administration. The A-I levels increased in three out of
four subjects after fat ingestion but no changes or even a slight decrease in the
levels of A-I were observed after intravenous fat infusion. The A-II levels also increased
after fat ingestion in two subjects but the levels either did not change or decreased
slightly after fat infusion. The levels of C-III increased concomitantly with the
increase of triglyceride levels after fat ingestion as well as fat infusion. After
intravenous fat infusion, part of the C-III in the d > 1.006 fraction shifted to the
lighter fraction (d < 1.006). These observations suggest that the increase in the
levels of A-I and A-II after fat ingestion are a consequence of an increase in apoprotein
synthesis in the intestine during fat absorption. The increase in the levels of C-III
after fat ingestion as well as fat infusion seemed to be related to the capture of
C-III in the triglyceride rich particles, i.e. C-III accumulated in the circulation
with triglyceride-rich particles. However, it appeared also to be possible that the
rate of C-III synthesis increases during hyperlipidemia induced by fat infusion.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to AtherosclerosisAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Lipoprotein apoprotein metabolism.J. Lipid Res. 1978; 19: 667
- Serum lipoprotein quantitation by immunochemical methods.in: Scanu A.M. Wissler R.W. Gets G.S. The Biochemistry of Atherosclerosis. Marcel Dekker, New York, NY1979: 189
- Human chylomicron apolipoprotein metabolism.Biochem. Biophys. Res. Comm. 1978; 80: 405
- Application of a new intravenous fat tolerance test in the study of hypertriglyceridemias in man.J. Atheroscler. Res. 1969; 9: 159
- Fractionation of human serum high density lipoprotein in urea solutions — Evidence for polypeptide heterogeneity.Biochemistry. 1969; 8: 3309
- Rapid fluorescent “staining” of non-denatured protein bands in agar and polyacrylamide gels.Anal. Biochem. 1971; 43: 564
- Immunochemical quantification of plasma high density lipoprotein.Physico-Chem. Biol. (Japan). 1975; 19: 55
- Apolipoprotein A-I in cholestatic liver diseases.Clin. Chim. Acts. 1978; 87: 85
- Relative contributions by liver and intestine to individual plasma apolipoproteins in the rat.J. Biol. Chem. 1979; 254: 7316
- Apoprotein A-I synthesis in normal intestinal mucosa and in Tangier disease.N. Engl. J. Med. 1978; 299: 1424
- Apoprotein synthesis by human duodenojejunal mucosa.Gastroenterology. 1978; 75: 677
- Relationship between triglyceride-rich lipoprotein (chylomicron and VLDL) and HDL2 and HDL3 in the postprandial phase in humans.Atherosclerosis. 1980; 37: 271
Article Info
Publication History
Accepted:
May 19,
1981
Received in revised form:
May 18,
1981
Received:
January 5,
1981
Footnotes
☆This work was partly supported by a research grant from the Japan Heart Foundation.
Identification
Copyright
© 1982 Published by Elsevier Inc.
